Skip to content

Advertisement

BMC Cancer

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study

  • Sabrina Falkowski1,
  • Jean-Baptiste Woillard2View ORCID ID profile,
  • Deborah Postil3,
  • Nicole Tubiana-Mathieu1,
  • Eric Terrebonne4,
  • Antoine Pariente5,
  • Denis Smith6,
  • Rosine Guimbaud7,
  • Claire Thalamas8,
  • Koukeb Rouguieg-Malki2,
  • Pierre Marquet2 and
  • Nicolas Picard2, 9Email author
BMC Cancer201717:901

https://doi.org/10.1186/s12885-017-3728-0

Received: 31 October 2016

Accepted: 30 October 2017

Published: 28 December 2017

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Oct 2016 Submitted Original manuscript
11 Mar 2017 Reviewed Reviewer Report - Jennifer Beebe-Dimmer
13 Mar 2017 Reviewed Reviewer Report - Xuezheng (Amy) Sun
15 Mar 2017 Reviewed Reviewer Report - Vibeke Andersen
22 Mar 2017 Reviewed Reviewer Report - Zhanwei Wang
25 Apr 2017 Author responded Author comments - Sabrina Falkowski
Resubmission - Version 2
25 Apr 2017 Submitted Manuscript version 2
10 Jul 2017 Reviewed Reviewer Report - Zhanwei Wang
20 Jul 2017 Reviewed Reviewer Report - Jennifer Beebe-Dimmer
10 Oct 2017 Author responded Author comments - Sabrina Falkowski
Resubmission - Version 3
10 Oct 2017 Submitted Manuscript version 3
Publishing
30 Oct 2017 Editorially accepted
28 Dec 2017 Article published 10.1186/s12885-017-3728-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Oncology Department, CHU Limoges, Limoges, France
(2)
UMR-1248, Inserm, CHU Limoges, Univ. Limoges, Limoges, France
(3)
Clinical Investigation Centre, CHU Limoges, Limoges, France
(4)
Hepato-gastro-enterology Department, University Hospital Bordeaux, Bordeaux, France
(5)
Pharmaco-epidemiology unit, University Hospital Bordeaux, Bordeaux, France
(6)
Oncology Department, University Hospital Bordeaux, Bordeaux, France
(7)
Digestive Oncology Department, University Hospital Toulouse, Toulouse, France
(8)
Clinical Investigation Centre, University Hospital Toulouse, Toulouse, France
(9)
Service de Pharmacologie, Toxicologie et Pharmacovigilance, Limoges, France

Advertisement